Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Identification of a Potential Inhibitor Targeting MurC Ligase of the Drug Resistant Pseudomonas aeruginosa Strain through Structure-Based Virtual Screening Approach and In Vitro Assay

Author(s): Abdelmonaem Messaoudi*, Manel Zoghlami, Zarrin Basharat and Najla Sadfi-Zouaoui

Volume 20, Issue 14, 2019

Page: [1203 - 1212] Pages: 10

DOI: 10.2174/1389201020666190719123133

Price: $65

Abstract

Background & Objective: Pseudomonas aeruginosa shows resistance to a large number of antibiotics, including carbapenems and third generation cephalosporin. According to the World Health Organization global report published in February 2017, Pseudomonas aeruginosa is on the priority list among resistant bacteria, for which new antibiotics are urgently needed. Peptidoglycan serves as a good target for the discovery of novel antimicrobial drugs.

Methods: Biosynthesis of peptidoglycan is a multi-step process involving four mur enzymes. Among these enzymes, UDP-N-acetylmuramate-L-alanine ligase (MurC) is considered to be an excellent target for the design of new classes of antimicrobial inhibitors in gram-negative bacteria.

Results: In this study, a homology model of Pseudomonas aeruginosa MurC ligase was generated and used for virtual screening of chemical compounds from the ZINC Database. The best screened inhibitor i.e. N, N-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazole-5-sulfonamide was then validated experimentally through inhibition assay.

Conclusion: The presented results based on combined computational and in vitro analysis open up new horizons for the development of novel antimicrobials against this pathogen.

Keywords: P. aeruginosa, virtual screening, structure modeling, molecular docking, MurC ligase, peptidoglycan.

« Previous Next »
Graphical Abstract

[1]
Morales, E.; Cots, F.; Sala, M.; Comas, M.; Belvis, F.; Riu, M.; Salvadó, M.; Grau, S.; Horcajada, J.P.; Montero, M.M.; Castells, X. Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Serv. Res., 2012, 12, 122.
[http://dx.doi.org/10.1186/1472-6963-12-122] [PMID: 22621745]
[2]
Satti, L.; Abbasi, S.; Qumar, T.A.; Khan, M.S.; Hashmi, Z.A. In vitro efficacy of cefepime against multi-drug resistant Pseudomonas aeruginosa an alarming situation in our setup. Open Drug Resist. J., 2011, 1, 12-16.
[http://dx.doi.org/10.2174/1876521101101010012]
[3]
Tohidpour, A.; Najar Peerayeh, S.; Mehrabadi, J.F.; Rezaei Yazdi, H. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor. Curr. Microbiol., 2009, 59(3), 352-355.
[http://dx.doi.org/10.1007/s00284-009-9444-5] [PMID: 19554368]
[4]
Kung, V.L.; Ozer, E.A.; Hauser, A.R. The accessory genome of Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev., 2010, 74(4), 621-641.
[http://dx.doi.org/10.1128/MMBR.00027-10] [PMID: 21119020]
[5]
Hancock, R.E.; Speert, D.P. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and impact on treatment. Drug Resist. Updat., 2000, 3(4), 247-255.
[http://dx.doi.org/10.1054/drup.2000.0152] [PMID: 11498392]
[6]
Aloush, V.; Navon-Venezia, S.; Seigman-Igra, Y.; Cabili, S.; Carmeli, Y. Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob. Agents Chemother., 2006, 50(1), 43-48.
[http://dx.doi.org/10.1128/AAC.50.1.43-48.2006] [PMID: 16377665]
[7]
Li, X.Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria. Drugs, 2004, 64(2), 159-204.
[http://dx.doi.org/10.2165/00003495-200464020-00004] [PMID: 14717618]
[8]
Wilson, D.N. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol., 2014, 12(1), 35-48.
[http://dx.doi.org/10.1038/nrmicro3155] [PMID: 24336183]
[9]
Tomašić, T.; Kovač, A.; Simčič, M.; Blanot, D.; Grdadolnik, S.G.; Gobec, S.; Kikelj, D.; Peterlin Mašič, L. Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting D-Glu- and diphosphate-binding sites. Eur. J. Med. Chem., 2011, 46(9), 3964-3975.
[http://dx.doi.org/10.1016/j.ejmech.2011.05.070] [PMID: 21703731]
[10]
Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev., 2011, 24(1), 71-109.
[http://dx.doi.org/10.1128/CMR.00030-10] [PMID: 21233508]
[11]
Green, D.W. The bacterial cell walls as a source of antibacterial targets. Expert Opin. Ther. Targets, 2002, 6(1), 1-19.
[http://dx.doi.org/10.1517/14728222.6.1.1] [PMID: 11901475]
[12]
El Zoeiby, A.; Sanschagrin, F.; Levesque, R.C. Structure and function of the Mur enzymes: Development of novel inhibitors. Mol. Microbiol., 2003, 47(1), 1-12.
[http://dx.doi.org/10.1046/j.1365-2958.2003.03289.x] [PMID: 12492849]
[13]
Bouhss, A.; Dementin, S.; van Heijenoort, J.; Parquet, C.; Blanot, D.; Mur, C.; Mur, D. MurC and MurD synthetases of peptidoglycan biosynthesis: Borohydride trapping of acyl-phosphate intermediates. Methods Enzymol., 2002, 354, 189-196.
[http://dx.doi.org/10.1016/S0076-6879(02)54015-5] [PMID: 12418226]
[14]
Fiuza, M.; Canova, M.J.; Patin, D.; Letek, M.; Zanella-Cléon, I.; Becchi, M.; Mateos, L.M.; Mengin-Lecreulx, D.; Molle, V.; Gil, J.A. The MurC ligase essential for peptidoglycan biosynthesis is regulated by the serine/threonine protein kinase PknA in Corynebacterium glutamicum. J. Biol. Chem., 2008, 283(52), 36553-36563.
[http://dx.doi.org/10.1074/jbc.M807175200] [PMID: 18974047]
[15]
Ehmann, D.E.; Demeritt, J.E.; Hull, K.G.; Fisher, S.L. Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-l-alanine ligase. Biochim. Biophys. Acta, 2004, 1698(2), 167-174.
[http://dx.doi.org/10.1016/j.bbapap.2003.11.006] [PMID: 15134649]
[16]
Zawadzke, L.E.; Norcia, M.; Desbonnet, C.R.; Wang, H.; Freeman-Cook, K.; Dougherty, T.J. Identification of an inhibitor of the MurC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway. Assay Drug Dev. Technol., 2008, 6(1), 95-103.
[http://dx.doi.org/10.1089/adt.2007.114] [PMID: 18315498]
[17]
Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M.C.; Estreicher, A.; Gasteiger, E.; Martin, M.J.; Michoud, K.; O’Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res., 2003, 31(1), 365-370.
[http://dx.doi.org/10.1093/nar/gkg095] [PMID: 12520024]
[18]
Colovos, C.; Yeates, T.O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci., 1993, 2(9), 1511-1519.
[http://dx.doi.org/10.1002/pro.5560020916] [PMID: 8401235]
[19]
Gill, S.C.; von Hippel, P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem., 1989, 182(2), 319-326.
[http://dx.doi.org/10.1016/0003-2697(89)90602-7] [PMID: 2610349]
[20]
Guruprasad, K.; Reddy, B.V.; Pandit, M.W. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng., 1990, 4(2), 155-161.
[http://dx.doi.org/10.1093/protein/4.2.155] [PMID: 2075190]
[21]
Ikai, A. Thermostability and aliphatic index of globular proteins. J. Biochem., 1980, 88(6), 1895-1898.
[PMID: 7462208]
[22]
Guermeur, Y.; Geourjon, C.; Gallinari, P.; Deléage, G. Improved performance in protein secondary structure prediction by inhomogeneous score combination. Bioinformatics, 1999, 15(5), 413-421.
[http://dx.doi.org/10.1093/bioinformatics/15.5.413] [PMID: 10366661]
[23]
Bernstein, F.C.; Koetzle, T.F.; Williams, G.J.; Meyer, E.F., Jr; Brice, M.D.; Rodgers, J.R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur. J. Biochem., 1977, 80(2), 319-324.
[http://dx.doi.org/10.1111/j.1432-1033.1977.tb11885.x] [PMID: 923582]
[24]
Schwede, T.; Kopp, J.; Guex, N.; Peitsch, M.C. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res., 2003, 31(13), 3381-3385.
[http://dx.doi.org/10.1093/nar/gkg520] [PMID: 12824332]
[25]
Gasteiger, E.; Gattiker, A.; Hoogland, C.; Ivanyi, I.; Appel, R.D.; Bairoch, A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res., 2003, 31(13), 3784-3788.
[http://dx.doi.org/10.1093/nar/gkg563] [PMID: 12824418]
[26]
Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics, 2006, 22(2), 195-201.
[http://dx.doi.org/10.1093/bioinformatics/bti770] [PMID: 16301204]
[27]
Scott, W.R.P.; Hunenberger, P.H.; Tironi, I.G.; Mark, A.E.; Billeter, S.R.; Fennon, J.; Torda, A.E.; Huber, T.; Kruger, P.; Van Gunsteren, W.F. The GROMOS biomolecular simulation program package. J. Phys. Chem. A, 1999, 103, 3596-3697.
[http://dx.doi.org/10.1021/jp984217f]
[28]
Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK a program to check the stereochemical quality of protein structures. J. Appl. Cryst., 1993, 26, 283-291.
[http://dx.doi.org/10.1107/S0021889892009944]
[29]
Bowie, J.U.; Lüthy, R.; Eisenberg, D. A method to identify protein sequences that fold into a known three-dimensional structure. Science, 1991, 253(5016), 164-170.
[http://dx.doi.org/10.1126/science.1853201] [PMID: 1853201]
[30]
Oprea, T.I.; Matter, H. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol., 2004, 8(4), 349-358.
[http://dx.doi.org/10.1016/j.cbpa.2004.06.008] [PMID: 15288243]
[31]
Irwin, J.J.; Shoichet, B.K.; Mysinger, M.M.; Huang, N.; Colizzi, F.; Wassam, P.; Cao, Y. Automated docking screens: A feasibility study. J. Med. Chem., 2009, 52(18), 5712-5720.
[http://dx.doi.org/10.1021/jm9006966] [PMID: 19719084]
[32]
Irwin, J.J.; Shoichet, B.K. ZINC--a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 2005, 45(1), 177-182.
[http://dx.doi.org/10.1021/ci049714+] [PMID: 15667143]
[33]
Lorber, D.M.; Shoichet, B.K. Flexible ligand docking using conformational ensembles. Protein Sci., 1998, 7(4), 938-950.
[http://dx.doi.org/10.1002/pro.5560070411] [PMID: 9568900]
[34]
Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46(1-3), 3-26.
[http://dx.doi.org/10.1016/S0169-409X(00)00129-0] [PMID: 11259830]
[35]
Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem., 2004, 25(13), 1605-1612.
[http://dx.doi.org/10.1002/jcc.20084] [PMID: 15264254]
[36]
Schachter, M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update. Fundam. Clin. Pharmacol., 2005, 19(1), 117-125.
[http://dx.doi.org/10.1111/j.1472-8206.2004.00299.x] [PMID: 15660968]
[37]
Barrow, G.I.; Feltham, R.K.A. Bacterial characters and characterization in COWAN and STEEL’S manual for the identification of medical bacteriaCambridge university press; \ Barrow, G.I.; Feltham, R.K.A., Eds.. 21-45. 1994 pp.
[38]
CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. In:Wayne, PA: Clinical and laboratory standards institute;; , 2012.
[39]
Smith, C.A.; Rayment, I. Active site comparisons highlight structural similarities between myosin and other P-loop proteins. Biophys. J., 1996, 70(4), 1590-1602.
[http://dx.doi.org/10.1016/S0006-3495(96)79745-X] [PMID: 8785318]
[40]
El Zoeiby, A.; Sanschagrin, F.; Lamoureux, J.; Darveau, A.; Levesque, R.C. Cloning, over-expression and purification of Pseudomonas aeruginosa murC encoding uridine diphosphate N-acetylmuramate: L-alanine ligase. FEMS Microbiol. Lett., 2000, 183(2), 281-288.
[http://dx.doi.org/10.1016/S0378-1097(00)00003-3] [PMID: 10675598]
[41]
Dundas, J.; Ouyang, Z.; Tseng, J.; Binkowski, A.; Turpaz, Y.; Liang, J. CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res.,, 2006, 34((Web Server issue)), W116-8.
[http://dx.doi.org/10.1093/nar/gkl282] [PMID: 16844972]
[42]
Reck, F.; Marmor, S.; Fisher, S.; Wuonola, M.A. Inhibitors of the bacterial cell wall biosynthesis enzyme MurC. Bioorg. Med. Chem. Lett., 2001, 11(11), 1451-1454.
[http://dx.doi.org/10.1016/S0960-894X(01)00251-7] [PMID: 11378375]
[43]
Marmor, S.; Petersen, C.P.; Reck, F.; Yang, W.; Gao, N.; Fisher, S.L. Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC. Biochemistry, 2001, 40(40), 12207-12214.
[http://dx.doi.org/10.1021/bi015567m] [PMID: 11580296]

Rights & Permissions Print Cite
Article Metrics
42
2
1
2
© 2024 Bentham Science Publishers | Privacy Policy